The UQ Vaccine Study
The University of Queensland is developing a vaccine technology that could be used to rapidly respond to future emerging infectious diseases, like COVID-19. This means that if successful, this new way of making vaccines could be applied to any future outbreaks of infectious diseases by making it quicker and easier to develop vaccines for emerging diseases.
The purpose of this study is to compare a potential COVID-19 vaccine developed by the University of Queensland with an already approved COVID-19 vaccine (NovaVax). It is hoped that by comparing both vaccines, the University of Queensland’s vaccine platform is validated.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.